TradingView
madhu2811
Jun 19, 2023 8:15 AM

Marksans Pharma Ltd Long

MARKSANS PHARMA LTDNSE

Description

Around 51% comes from Pain Management, 11% comes from Cough & Cold, 8% comes from Cardiovascular System, 6% comes from Gastrointestinal, and the rest comes from Anti-Diabetic, AntiAllergic.

TARGET AND STOPLOSS IN CHART

Market Cap
₹ 4,176 Cr.

Current Price
₹ 92.2

High / Low
₹ 94.3 / 38.6

Stock P/E
15.8

Book Value
₹ 38.5

Dividend Yield
0.54 %

ROCE
22.5 %

ROE
18.6 %

Face Value
₹ 1.00

Promoter holding
43.8 %

EPS last year
₹ 5.88

EPS latest quarter
₹ 1.81

Debt
₹ 123 Cr.

Pledged percentage
0.00 %

Net CF
₹ 176 Cr.

Price to Cash Flow
17.6

Free Cash Flow
₹ 184 Cr.

Debt to equity
0.07

OPM last year
18.3 %

OPM 5Year
18.4 %

Reserves
₹ 1,700 Cr.

Price to book value
2.31

Int Coverage
38.0

PEG Ratio
0.31

Trade active

Trade active

10 % up

Trade active

T2 DOne

Trade active

Target Done Trail SL
Comments
forsakenGear54849
Sir abhi T1 achieve hua hai T2 nhi
madhu2811
Marksans Pharma
#MARKSANS
Good Q1FY24
Rev at 500cr vs 433cr
PBT at 97cr vs 76cr,q4 at 104cr
Some upfront costs for commissioning Teva facility
Higher tax rate in UK
PAT at 70cr vs 60cr
forsakenGear54849
Great
lalitacharya1983
good sir
More